Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Risk adjusted net present value: What is the current valuation of GSK's GSK-3943104A?
GSK-3943104A is a subunit vaccine commercialized by GSK, with a leading Phase II program in Genital Herpes. According to Globaldata,...
Data Insights
GSK-3943104A by GSK for Genital Herpes: Likelihood of Approval
GSK-3943104A is under clinical development by GSK and currently in Phase II for Genital Herpes. According to GlobalData, Phase II...